Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.000
+0.160 (4.17%)
At close: Jan 22, 2026, 4:00 PM EST
4.080
+0.080 (2.00%)
After-hours: Jan 22, 2026, 6:46 PM EST

Organogenesis Holdings Revenue

Organogenesis Holdings had revenue of $150.86M in the quarter ending September 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to $465.22M, up 2.24% year-over-year. In the year 2024, Organogenesis Holdings had annual revenue of $482.04M with 11.29% growth.

Revenue (ttm)
$465.22M
Revenue Growth
+2.24%
P/S Ratio
1.05
Revenue / Employee
$535,349
Employees
869
Market Cap
509.55M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024482.04M48.90M11.29%
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020338.30M77.32M29.63%
Dec 31, 2019260.98M67.53M34.91%
Dec 31, 2018193.45M-5.06M-2.55%
Dec 31, 2017198.51M59.78M43.09%
Dec 31, 2016138.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition